Literature DB >> 10566602

Relative HLA-DRB1*13 allele frequencies and DRB3 associations of unrelated individuals from five US populations.

D M Sintasath1, T Tang, R Slack, E E Tilley, J Ng, R J Hartzman, C K Hurley.   

Abstract

The frequencies of 30 HLA-DRB1*13 alleles and 15 DRB3 alleles were determined for the 5 major U.S. ethnic populations: Caucasians, African Americans, Asian/Pacific Islanders, Hispanics, and Native Americans. A random sampling (163) of DRB1*13-positive individuals from each self-described ethnic group was selected out of a pool of 82,979 unrelated individuals, providing at least an 80% probability of detecting a rare allele that occurred at 1%. These 815 samples were subjected to allele-level SSOP typing and/or DNA sequencing which identified 11 different DRB1*13 alleles. DRB1*1301 and DRB1*1302 were the most common alleles seen in the five major ethnic groups while DRB1*1304 was not detected among Caucasians and DRB1*1305 was not detected among African Americans. DRB1*13 allele diversity was surprisingly more limited among African Americans compared to both Caucasians and Asian/Pacific Islanders. To determine the extent of DRB1*13-DRB3 associations, 504 of these samples expressing only one DRB3-associated DRB1 allele were subjected to PCR-SSOP typing and 14 DRB1*13-DRB3 haplotypes were detected. The distribution revealed that African Americans were significantly different from Caucasians, Asian/Pacific Islanders, and Hispanics. Allele frequency studies such as this further support previous findings that the distribution of HLA types can differ significantly among different ethnic populations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566602     DOI: 10.1016/s0198-8859(99)00085-3

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  6 in total

1.  Major histocompatibility complex class II (HLA-DRB and -DQB) allele frequencies in Botswana: association with human immunodeficiency virus type 1 infection.

Authors:  Thumbi Ndung'u; Simani Gaseitsiwe; Enoch Sepako; Florence Doualla-Bell; Trevor Peter; Soyeon Kim; Ibou Thior; Vladimir A Novitsky; Max Essex
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

2.  Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment.

Authors:  U Malhotra; S Holte; S Dutta; M M Berrey; E Delpit; D M Koelle; A Sette; L Corey; M J McElrath
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  Reassessing the role of HLA-DRB3 T-cell responses: evidence for significant expression and complementary antigen presentation.

Authors:  Rosa Faner; Eddie James; Laurie Huston; Ricardo Pujol-Borrel; William W Kwok; Manel Juan
Journal:  Eur J Immunol       Date:  2010-01       Impact factor: 5.532

4.  HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

Authors:  Milton D Rossman; Bruce Thompson; Margaret Frederick; Mary Maliarik; Michael C Iannuzzi; Benjamin A Rybicki; Janardan P Pandey; Lee S Newman; Eleni Magira; Bojana Beznik-Cizman; Dimitri Monos
Journal:  Am J Hum Genet       Date:  2003-08-20       Impact factor: 11.025

5.  Components of the ligand for a Ni++ reactive human T cell clone.

Authors:  Linh Lu; Jörg Vollmer; Corinne Moulon; Hans Ulrich Weltzien; Philippa Marrack; John Kappler
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

6.  The effects of human leukocyte antigen DRB1*13 and apolipoprotein E on age-related variability of synchronous neural interactions in healthy women.

Authors:  Lisa M James; Stacy Dolan; Arthur C Leuthold; Brian E Engdahl; Angeliki Georgopoulos; Apostolos P Georgopoulos
Journal:  EBioMedicine       Date:  2018-08-20       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.